Press release
Global Cardiac Biomarkers Testing Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Cardiac Biomarkers Testing
How Big Is the Cardiac Biomarkers Testing Market Size Expected to Be by 2034?
The market size of cardiac biomarkers testing has seen significant growth in recent years. The market, which is expected to be valued at $13.48 billion in 2024, is projected to increase to $15.09 billion in 2025, highlighting a compound annual growth rate (CAGR) of 12.0%. The growth experienced during the historical period is associated with factors such as the rise in cardiovascular disease cases, an aging global population, an increase in health awareness and educational initiatives, government-led health initiatives and policies, along with heightened healthcare expenditure.
Anticipations are high for the cardiac biomarkers testing market, which is predicted to undergo significant expansion in the coming years. By 2029, it is projected to reach $23.75 billion, growing at a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this projected growth include the adoption of personalized medicine, the escalating global incidence of cardiovascular diseases, the use of artificial intelligence (AI) in diagnostic processes, the development of point-of-care testing, and an enhanced focus on the early detection of diseases. Furthermore, the forecast period is expected to witness trends such as technological innovation, advancements in AI-supported diagnostics, the growth of point-of-care testing (POCT), expansion in multiplexing capabilities, and ongoing discovery and validation of biomarkers.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
What Are the Emerging Segments Within the Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market covered in this report is segmented -
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
What Long-Term Drivers Are Shaping Cardiac Biomarkers Testing Market Trends?
The anticipated rise in cardiovascular disorders is projected to spur the growth of the cardiac biomarkers testing market. Such a disease encompasses conditions that impact the heart or blood vessels. Cardiac biomarker examinations help to ascertain the biomarker levels to instantly evaluate the intensity of a heart attack and its size. Thus, a rise in cardiovascular disease prevalence will surge the need for cardiac biomarker testing solutions. For example, in August 2022, the American College of Cardiology, a medical professional organization based in the US, predicted that the rates of cardiovascular risk factors and disease will significantly ascend in the United States by 2060. Hence, increasing incidents of cardiovascular diseases are propelling the growth of the cardiac biomarkers testing market.
Who Are the Top Competitors in Key Cardiac Biomarkers Testing Market Segments?
Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
What Cardiac Biomarkers Testing Market Trends Are Gaining Traction Across Different Segments?
Leading firms in the cardiac biomarker testing market are leveraging strategic partnerships to offer technology capable of identifying early indications of heart conditions and enhancing patient prognosis. Such partnerships promote inter-company cooperation, paving the way for inventive diagnostics, widening market penetration, and speeding up the distribution of cutting-edge testing solutions for superior cardiovascular treatment. For instance, MediBuddy, a health technology entity based in India, offering a complete suite of telehealth, health management, and insurance services, joined forces with Philips, a multinational corporation based in the Netherlands, in September 2024. The aim of this partnership is to advance cardiac treatment in India by integrating Philips' HeartPrint technology, allowing for routine monitoring and risk evaluation of heart health. This progressive strategy provides users on the MediBuddy platform with sophisticated tools, promoting a proactive approach to heart health management for improved outcomes.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Which Regions Are Becoming Hubs for Cardiac Biomarkers Testing Market Innovation?
North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Cardiac Biomarkers Testing Market?
2. What is the CAGR expected in the Cardiac Biomarkers Testing Market?
3. What Are the Key Innovations Transforming the Cardiac Biomarkers Testing Industry?
4. Which Region Is Leading the Cardiac Biomarkers Testing Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cardiac Biomarkers Testing Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 3976983 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
